BioNexus Gene Lab issues 410,000 shares for $3.5M licence
BioNexus Gene Lab (BGLC) is issuing 410,000 common shares at closing as licence consideration of $3.5 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.